Nitisinone (INN), also known as NTBC is a medication used to slow the effects of
hereditary tyrosinemia type 1. Since its first use for this indication in 1991, it has ...
ORFADIN contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase
inhibitor indicated as an adjunct to dietary restriction of tyrosine and ...
Nov 5, 2014 ... Nitisinone works by preventing the body from breaking down an amino acid
called tyrosine and by keeping other toxic substances from building ...
Description, Nitisinone is a synthetic reversible inhibitor of 4-
hydroxyphenylpyruvate dioxygenase. It is used in the treatment of hereditary
tyrosinemia type 1.
Consumer information about the medication NITISINONE - ORAL (Orfadin),
includes side effects, drug interactions, recommended dosages, and storage ...
Apr 26, 2016 ... ORFADIN® (nitisinone) blocks the breakdown of tyrosine, thereby reducing the
amount of toxic by-products in the body. In the most common ...
Metabolism. 2005 Jun;54(6):719-28. Use of nitisinone in patients with
alkaptonuria. Suwannarat P(1), O'Brien K, Perry MB, Sebring N, Bernardini I, ...
Jan 18, 2002 ... Orfadin® capsules contain nitisinone, which is a synthetic reversible inhibitor of.
4-hydroxyphenylpyruvate dioxygenase used in the treatment of ...
ORFADIN® capsules (nitisinone) are indicated as an adjunct to dietary restriction
of tyrosine and phenylalanine in the treatment of patients with hereditary ...
Drug information and side-effects for Orfadin (nitisinone)